Xbrane Biopharma AB (publ) (STO: XBRANE)
Sweden
· Delayed Price · Currency is SEK 0.185
+0.004 (2.44%)
Nov 29, 2024, 5:29 PM CET
Xbrane Biopharma AB Revenue
Xbrane Biopharma AB had revenue of 66.81M SEK in the quarter ending September 30, 2024, with 13.45% growth. This brings the company's revenue in the last twelve months to 199.81M, up 5.64% year-over-year. In the year 2023, Xbrane Biopharma AB had annual revenue of 238.73M with 314.33% growth.
Revenue (ttm)
199.81M
Revenue Growth
+5.64%
P/S Ratio
0.77
Revenue / Employee
3.07M
Employees
93
Market Cap
276.53M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 17.72B |